News

They ask about reprogramming cells and how the company is aiming to develop cell therapies.

The article offers 6 tips for successful pharma startups.

This case study delves into the company story, technology and vision.

The list looks at how companies are performing and what they are working on.

Technology Networks cover the development, benefits and applications of ioSkeletal Myocytes.

Founder and CEO Dr Mark Kotter joined the experts who have given their thoughts on what is to come for the health sector in 2022.

Wired spoke to bit.bio's CEO and CMO about reprogramming cells for therapies.

The Charles River's Laboratories Disruptor series celebrates the work of their innovative partners.